SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-20-004260
Filing Date
2020-07-27
Accepted
2020-07-27 16:36:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 a2242100z424b5.htm 424B5 347092
2 G972346.JPG g972346.jpg GRAPHIC 31210
3 G1016027.JPG g1016027.jpg GRAPHIC 16221
  Complete submission text file 0001047469-20-004260.txt   413629
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-240118 | Film No.: 201050788
SIC: 2834 Pharmaceutical Preparations